Bactericidal Activity of Rifampin-Amikacin against Mycobacterium ulcerans in Mice

To identify the most active curative treatment of Buruli ulcer, two regimens incorporating the use of rifampin (RIF) were compared with the use of RIF alone in a mouse footpad model of Mycobacterium ulcerans infection. Treatments began after footpad swelling from infection and continued for 12 weeks...

Descripció completa

Dades bibliogràfiques

Publicat a:	Antimicrob Agents Chemother
Autors principals:	Dega, Herve, Bentoucha, Abdelhalim, Robert, Jerome, Jarlier, Vincent, Grosset, Jacques
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 2002
Matèries:	Experimental Therapeutics
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC128793/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12234844/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.46.10.3193-3196.2002
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!